The FDA approved the antibacterial drug trio imipenem, cilastatin, and relebactam for adults with complicated urinary tract infections and complicated intra-abdominal infections.
FDA Approvals …read more
The FDA approved the antibacterial drug trio imipenem, cilastatin, and relebactam for adults with complicated urinary tract infections and complicated intra-abdominal infections.
FDA Approvals …read more